Ankita Bansal

Employment

• Jio Institute Assistant Professor
  2023 - Present
• The Mount Sinai Hospital Postdoctoral Fellow
  2018 - 2023
• University of Pennsylvania Postdoctoral Fellow
  2014 - 2018

Education

• University of Massachusetts Medical School Graduate School of Biomedical Sciences PhD
  2008 - 2014

Projects & Funding

Projects & funding information is unavailable.

Publications (32)

• Data from AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway–Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B
  2023 DOI: 10.1158/2159-8290.c.6549418
  +Save
• Author Correction: A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma (Nature Communications, (2022), 13, 1, (6041), 10.1038/s41467-022-33377-8)
  Nature Communications 2023 DOI: 10.1038/s41467-023-37640-4
  +Save
• Supplementary Table from AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway–Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B
  2023 DOI: 10.1158/2159-8290.22540579
  +Save
• Supplementary Table from AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway–Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B
  2023 DOI: 10.1158/2159-8290.22540579.v1
  +Save
• Supplementary Table from AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway–Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B
  2023 DOI: 10.1158/2159-8290.22540576
  +Save
• Supplementary Table from AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway–Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B
  2023 DOI: 10.1158/2159-8290.22540576.v1
  +Save
• Supplementary Figure from Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma
  2023 DOI: 10.1158/1541-7786.22527686
  +Save
• Supplementary Figure from Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma
  2023 DOI: 10.1158/1541-7786.22527689
  +Save
• Supplementary Figure from Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma
  2023 DOI: 10.1158/1541-7786.22527692
  +Save
• Supplementary Figure from Loss of PBRM1 Alters Promoter Histone Modifications and Activates ALDH1A1 to Drive Renal Cell Carcinoma
  2023 DOI: 10.1158/1541-7786.22527683
  +Save